Bluebird bio has molted to reveal a new—or new-ish, at least—brand identity. After a busy summer that saw the drugmaker sell itself to a pair of private equity firms, go private and install new ...

SOMERVILLE, Mass., September 18, 2025--(BUSINESS WIRE)--bluebird bio, Inc. today announced it has rebranded as Genetix Biotherapeutics Inc., returning to its foundational roots. Genetix, now ...

Bluebird bio has rebranded to Genetix Biotherapeutics, marking a new chapter for the company that was once a frontrunner in the burgeoning cell and gene therapy (CGT) market. The brand change sees the ...

Company Focused On Advancing Breakthrough Clinical Programs in Gene Therapy Cambridge, MA - March 12, 2010 - Genetix Pharmaceuticals, a leading gene therapy company developing breakthrough treatments ...

Operational real-world data analyzed from patients prescribed ZYNTEGLO™ and LYFGENIA™ Oral presentation of recent patient experience data demonstrating the value proposition of gene therapy More than ...

Genetix Pharmaceuticals, Inc. one of the leading companies in gene therapy, has secured $35 million in series B funding from investors Third Rock Ventures and Genezyme Joint Ventures. This is a sign ...

Cambridge, MA-based Genetix Pharmaceuticals has completed a $35 million Series B financing with new investors Third Rock Ventures and Genzyme Ventures joining TVM Capital, Forbion and Easton Capital.

Genetix Ltd, a provider of solutions for imaging and image analysis, has been acquired by Leica Microsystems. This acquisition brings together Genetix’ expertise in developing and marketing imaging ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Mark Reid has a homely way to describe what his company does: “Think of companies that make the kit to produce ...

In recent years, advancements in the science of genetics have started to feel a lot more tangible. That’s due in no small part to the millions of people testing their DNA to discover their genealogy, ...

Simply sign up to the US companies myFT Digest -- delivered directly to your inbox. Biotechnology group Genetix is set to be taken over by Danaher, following a bid from the US diversified manufacturer ...